Targeting HER2 & FAP to Address Unmet Need With New Treatment Modality
Time: 11:25 am
day: Day 1 - Track A (AM)
Details:
• Why we have selected HER2 and FAP as our lead targets
• How we stand out from competition
• Sharing accomplishments and future plans
